Patent Prosecution · USPTO
Patent Office Action
Most patent applications receive at least one Office Action — a formal written rejection from the USPTO examiner. Understanding the types of rejections, your response options, and the critical deadlines is essential to getting your patent granted.
Critical deadline
Response deadline is calculated from the mailing date on the Office Action — not the date you receive it. Standard response period = 3 months (extendable to 6 months maximum with fees). At 6 months, the application automatically abandons under 35 U.S.C. § 133 with no further extension.
Types of Office Actions
Four types of USPTO office actions
Non-Final Office Action
The examiner's first substantive rejection of the application. The non-final OA includes a prior art search, claim rejections with citations, objections to the specification/drawings, and any formal issues. After a non-final OA, applicant has broad latitude to respond: full claim amendments are permitted, new arguments and evidence can be submitted, and the response can be as comprehensive as needed. A complete response to a non-final OA is required — a response that does not address every rejection and objection is treated as non-responsive.
Deadline: 3 months from the mailing date (no surcharge). Extendable to 6 months maximum with progressive extension fees.
Options: Full claim amendments, arguments, new evidence (declarations, affidavits), examiner interview, continuation filing.
Final Office Action
Usually the second substantive Office Action. The designation 'final' does not mean prosecution is over — it triggers a different set of rules that limit what the applicant can do as of right. After a final OA, the applicant can no longer freely amend all claims. Amendments that would require further search or consideration by the examiner are not entered as a matter of right. Options after a final OA include: (1) AFCP 2.0 request with a narrow amendment; (2) Pre-Appeal Brief Conference (PABQ); (3) Request for Continued Examination (RCE); (4) Appeal to PTAB.
Deadline: 3 months from mailing (no surcharge). Extendable to 6 months with fees. At 6 months, application goes abandoned if no action is taken.
Options: AFCP 2.0, RCE, Pre-Appeal Brief Conference, Notice of Appeal to PTAB, filing a continuation/divisional before abandonment.
Restriction Requirement
Not a rejection of the merits — the examiner determines that the application contains claims for two or more distinct inventions that can be separately classified (37 C.F.R. § 1.141). The applicant must elect one group of claims to proceed with in this application. The non-elected claims can be pursued in a divisional application filed before the parent application issues. A restriction requirement can be traversed (challenged) in the response, but even if traversed, prosecution on the elected claims continues while the traversal is pending. If the examiner maintains the restriction, the applicant can appeal.
Deadline: 3 months from mailing (extendable to 6 months with fees).
Options: Elect a claim group; traverse the restriction requirement with arguments; file divisional applications for non-elected inventions.
Ex Parte Quayle Action
Issued when all claims are allowable on the merits but there are only formal objections remaining — typically to the specification language, drawings, or abstract. This is a positive sign that prosecution is nearly complete. The response deadline is 2 months from mailing (shorter than a typical OA), extendable to 6 months. The applicant needs only to correct the formal issues; no new substantive rejections are open.
Deadline: 2 months from mailing (extendable to 6 months maximum with fees).
Options: Correct formal objections (amend specification/drawings, correct abstract); limited to formal corrections only.
Response Deadlines
Extension periods and surcharge fees
Rejection Types & Strategies
How to respond to each type of rejection
§ 102 — Anticipation
The examiner has found a single prior art reference that discloses every element of the claim. For anticipation, all limitations must be explicitly or inherently present in one reference — the examiner cannot combine multiple references for a § 102 rejection.
Response strategies
- Argue element-by-element: show that the prior art reference does NOT disclose at least one claim element — read the reference carefully and compare against each claim limitation.
- Argue inherency: if the examiner argues that an element is 'inherently' present, challenge whether the prior art necessarily and inevitably produces the claimed result (Scaltech Inc. v. Retec/Tetra LLC, Fed. Cir. 2000).
- Argue claim construction: show the examiner is reading the claim too broadly; narrow the claim construction to exclude the prior art embodiment.
- Amend the claim: add the missing limitation to the independent claim to distinguish from the prior art. This creates prosecution history estoppel for that limitation.
§ 103 — Obviousness
The examiner combines two or more prior art references to cover all claim elements, arguing a person having ordinary skill in the art (PHOSITA) would have been motivated to combine the references and had a reasonable expectation of success (KSR v. Teleflex, S.Ct. 2007).
Response strategies
- Challenge motivation to combine: argue that the references teach away from the combination; argue that the references are in different fields; argue that combining them would destroy the function of the primary reference.
- Challenge reasonable expectation of success: argue that combining the references would not have been predictable or reliable.
- Submit secondary considerations (objective indicia of non-obviousness): commercial success of the invention (must show nexus between success and claimed features); long-felt but unresolved need; failure of others; unexpected results; industry skepticism; praise from experts; licensing by others.
- Amend claims: add limitations not found in any single reference, not suggested by the combination, or that produce an unexpected result.
§ 101 — Patent-Eligible Subject Matter
The claim is directed to an abstract idea, law of nature, or natural phenomenon, and does not have 'significantly more' than the abstract idea itself. The Alice/Mayo framework: Step 1 = Is the claim directed to an abstract idea? If yes, Step 2A/B = Does the claim add significantly more (a specific technical feature integrated into a practical application)?
Response strategies
- Argue that the claim is integrated into a practical application: show the claim has a specific technical effect, solves a technical problem, or improves a technical process (not just implementing the abstract idea on a computer).
- Amend to add concrete technical limitations: add hardware specifics, data structure details, network topology, physical operations, or other concrete implementation details that tie the claim to a specific technology.
- Argue the claim is not directed to an abstract idea: argue under Step 1 that the claim is directed to a specific technical improvement, not an abstract idea per se.
- Use the USPTO Subject Matter Eligibility guidance: the USPTO's January 2019 guidance and subsequent examples provide frameworks for arguing §101 allowability — reference these in the response.
§ 112(a) — Written Description / Enablement
§ 112(a) contains two requirements: (1) Written description — the specification must show the applicant actually possessed the claimed invention at the time of filing; (2) Enablement — the specification must enable a PHOSITA to make and use the invention without undue experimentation.
Response strategies
- Written description: argue the specification contains a disclosure of the claimed features — point to specific paragraphs, figures, examples. For genus claims (especially in biotech/pharma), cite structural similarity or representative species.
- Enablement: argue minimal experimentation required using the Wands factors (Wands, Fed. Cir. 1988): predictability of art, skill level of PHOSITA, scope of claims, amount of guidance, number of working examples. For biotech: cite Amgen v. Sanofi (S.Ct. 2023) on genus claim enablement — functional claims must be enabled across their full scope.
- Amend claims: narrow the scope to what is clearly enabled in the specification; add examples and embodiments that are well-supported.
§ 112(b) — Definiteness
The claim uses indefinite language — a term of degree without adequate definition, a subjective standard with no objective anchor, relative terms that cannot be construed with reasonable certainty by a PHOSITA (Nautilus v. Biosig Instruments, S.Ct. 2014 — reasonable certainty standard).
Response strategies
- Argue the claim is definite: show the specification provides a clear definition or examples from which the term's meaning can be determined with reasonable certainty; cite Federal Circuit case law defining similar terms.
- Amend the claim: replace indefinite terms with specific, measurable limitations; replace relative terms ('substantially', 'approximately', 'about') with numerical ranges from the specification, or remove them if not essential.
Double Patenting (Obviousness-Type)
The examiner rejects the claims as being an obvious variant of claims in another patent application or issued patent by the same inventive entity (or assignee). Obviousness-type double patenting (ODP) is a judicially created doctrine designed to prevent patent term extension by successive, slightly different claims to the same invention.
Response strategies
- File a Terminal Disclaimer: the most common response to ODP rejections. The applicant disclaims the portion of the patent term that would extend beyond the expiration of the earlier patent (and typically agrees to assign both patents together). The terminal disclaimer form (PTO/SB/20) must be signed by the applicant/assignee. A terminal disclaimer resolves ODP but ties the two patents' terms together.
- Argue non-obviousness: show the claims are patentably distinct from the reference patent's claims — this is an argument that the new claims are not an obvious variant.
After Final Office Action
Options after a final rejection
AFCP 2.0 — After Final Consideration Pilot
File a response under the After Final Consideration Pilot 2.0 program. The examiner receives 3 additional hours to consider the amendment. If the amendment places all claims in condition for allowance without requiring further search or consideration, the examiner can allow the application without an RCE. AFCP 2.0 does not change the 'final' status — if the examiner issues another action, it remains final.
Best when: Best when you have a narrow, targeted amendment that clearly addresses the examiner's sole concern; the amendment doesn't open up new prior art; and the examiner has been responsive to arguments.
Fee: No additional USPTO fee (but must be filed before abandonment).
Pre-Appeal Brief Request for Review (PABQ)
Before formally filing a notice of appeal, applicant can request a pre-appeal brief conference. A 3-examiner panel (including supervisory patent examiner) reviews the final rejection and the applicant's 2-page brief. The panel may allow claims, reopen prosecution (non-final OA), or affirm. If affirmed, the applicant can then file a notice of appeal.
Best when: Best when there is a legal or technical error in the rejection that can be explained briefly; not effective for complex claim construction disputes; cannot submit new evidence in the PABQ request.
Fee: No separate USPTO fee (but applicant must have already filed a notice of appeal fee is $860 small entity; pre-appeal brief request is submitted with appeal filing).
Request for Continued Examination (RCE)
An RCE reopens prosecution by paying a fee and submitting a supplemental response (or a statement that the response is the record). After an RCE, the examiner issues a new (non-final) Office Action — prosecution restarts. Applicants can file an unlimited number of RCEs, though each costs money and adds delay. An RCE is NOT a new application — the application number and filing date remain the same.
Best when: Best when: the prior art issues can be addressed with targeted claim amendments; the examiner is likely to allow amended claims; you want to introduce new evidence or arguments that weren't in the record; you need more time to find additional prior art or commercial success evidence.
Fee: Large entity: $1,700 (first RCE), $2,000 (second+ RCE). Small entity: $850/$1,000. Micro entity: $425/$500 (approximate 2024 fees).
Notice of Appeal to PTAB
The applicant appeals the final rejection to the Patent Trial and Appeal Board (PTAB) by filing a Notice of Appeal and paying the appeal fee within the response period. After filing the Notice of Appeal, the applicant has 2 months to file an Appeal Brief (extendable to 6 months with fees). PTAB reviews both law and fact de novo on legal questions; factual findings by the examiner are reviewed for substantial evidence.
Best when: Best when: the legal arguments are strong and the record is complete; the examiner has made a clear legal error (misread a claim, combined references incorrectly, applied the wrong standard); the claims are in good shape and an appeal is more cost-effective than multiple RCEs.
Fee: Notice of Appeal: $860 small entity. Appeal Brief: $1,000 small entity. Oral hearing (optional): $500 small entity. Total appeal through PTAB: $2,360 small entity in USPTO fees alone (attorney fees additional).
File a Continuation or Divisional Application
Before the parent application abandons (or before it issues), the applicant can file a continuation (same disclosure, different or amended claims), continuation-in-part (CIP, adds new matter), or divisional (different invention group from a restriction requirement) application. This preserves the priority date and keeps prosecution alive on different claims — often a backup strategy run in parallel with an RCE or appeal.
Best when: Always consider filing a continuation before the parent issues if there may be need for different claim scope later — continuations can capture new embodiments, respond to future competitor products, or provide fallback claim sets. Must be filed while parent application is pending (not after it issues or is abandoned without revival).
Fee: Same as an original application filing: approximately $1,760–$3,760 for small entity utility patent (filing + search + exam fees).
FAQ
Frequently asked questions
What is the deadline to respond to a USPTO patent Office Action?
The standard response period for a USPTO Office Action is 3 months from the mailing date. The response period can be extended up to a maximum of 6 months (3 months' worth of extensions) by paying progressive extension fees. Important: the deadline is calculated from the MAILING DATE of the Office Action shown on the form, not the date you receive it. Extension fees for small entity applicants (approximate 2024 rates): 1-month extension = $250; 2-month extension = $700 (cumulative); 3-month extension = $1,650 (cumulative). For Ex Parte Quayle Actions (formal objections only), the standard response period is 2 months (not 3 months), but the same 6-month maximum applies with extensions. CRITICAL: the 6-month response period is an absolute statutory deadline under 35 U.S.C. § 133. If no response is filed within 6 months of the mailing date, the application is automatically ABANDONED. There is no further extension possible. An abandoned application can sometimes be revived — if the abandonment was unintentional, file a petition to revive under 37 C.F.R. § 1.137(a) with a fee (approximately $2,000 small entity) and a statement that the abandonment was unintentional. However, revival is not guaranteed and creates a gap in prosecution that may affect some rights.
What are secondary considerations (objective indicia of non-obviousness) and how do they work?
Secondary considerations — also called objective indicia of non-obviousness — are evidence that the invention was not obvious even though the individual elements might be found in prior art. They were established in Graham v. John Deere (S.Ct. 1966) as the fourth factor in the obviousness inquiry (the primary three factors are scope and content of prior art, differences between prior art and the claims, and level of ordinary skill in the art). Courts and the USPTO consider secondary considerations as evidence that the invention was not trivial or predictable. The recognized categories: (1) Commercial success: the invention has achieved significant commercial success in the marketplace. The patentee must show a nexus — a connection between the commercial success and the CLAIMED FEATURES, not just the product brand or marketing. Nexus can be shown by market data, revenue figures, or expert testimony. (2) Long-felt but unresolved need: experts in the field recognized a problem for years but failed to solve it — then the invention solved it. The need must be specifically for what the invention claims, and the need must have been recognized in the literature or industry. (3) Failure of others: other researchers, competitors, and skilled practitioners tried and failed to develop what the invention provides — showing the problem was not obvious to solve. (4) Unexpected results: the invention produces a result that is surprisingly better than what was expected from the prior art — for example, a claimed combination of compounds produces 10× the expected synergy. Must be supported by comparative data in the specification or a declaration. (5) Skepticism of experts: the invention contradicted prevailing wisdom; experts were skeptical it would work. (6) Praise from experts: leaders in the field praised the invention as a significant advance. (7) Teaching away: the prior art taught against or discouraged the claimed approach. (8) Industry licensing: others in the industry took licenses — implying they recognized the invention's value and non-obviousness. How to submit: secondary considerations are typically submitted by declaration (37 C.F.R. § 1.132 declaration) from the inventor or a technical expert, together with supporting data. The USPTO must consider them when timely submitted.
What is the difference between an RCE and a continuation application?
Both a Request for Continued Examination (RCE) and a continuation application allow continued prosecution, but they function differently. RCE (37 C.F.R. § 1.114): An RCE reopens prosecution of the SAME application — the same serial number, same filing date, same claims (unless amended). Prosecution resumes at the non-final OA stage. After an RCE, the applicant receives a new non-final Office Action (typically). The patent term runs from the original filing date, so RCEs consume patent term adjustment potential (PTA) — excessive delays caused by filing multiple RCEs do NOT add PTA days. RCEs do not create separate prosecution histories or separate patent files. Cost: ~$850 small entity, $1,700 large entity per RCE. Continuation Application (37 C.F.R. § 1.53(b)): A new application that claims priority to the parent application's filing date. The continuation has its own serial number and generates its own patent (if allowed). Patent term runs from the continuation's own filing date (though this equals the parent's priority date for 20-year term calculation). A continuation can have DIFFERENT claims than the parent — it can pursue broader, narrower, or different aspects of the invention. Continuations can be filed at any time while the parent is pending (including after an RCE). After the parent issues, continuations cannot be filed on the same disclosure. Key strategic difference: use an RCE when you want to continue prosecution of the SAME application with the SAME examiner on largely the SAME claims; use a continuation when you want a separate patent, different claim scope, or to capture new product embodiments. RCEs and continuations are NOT mutually exclusive — you can file both (an RCE on the main application and a continuation in parallel) to maintain maximum flexibility.
What is an examiner interview and should I request one?
An examiner interview is a direct conversation — by telephone, video conference, or in-person at the USPTO — between the patent applicant (or their attorney/agent) and the examining attorney. Interviews are governed by 37 C.F.R. § 1.133. After an interview, the examiner enters an Examiner Interview Summary into the application file, and the applicant must also file an Applicant-Initiated Interview Request (AIIR) or a summary of the agreed-upon points. When to request an interview: (1) Before responding to a non-final OA — an interview can clarify exactly what amendments would make the claims allowable, potentially avoiding multiple rounds of prosecution; (2) Before responding to a final OA — a pre-brief conference or telephonic interview may reveal whether the examiner is willing to allow claims with specific amendments, allowing an AFCP 2.0 response instead of an expensive RCE; (3) When prosecution is stuck — after 2-3 rounds of rejections on the same grounds, an interview with the examiner and their supervisor (supervisory patent examiner, SPE) can break the impasse. How to request: use the USPTO's Interview Request form (PTO-135 or via PAIR); provide a brief summary of the proposed agenda and proposed claim amendments. The examiner is not required to grant an interview, but they generally do. Best practices: (1) prepare a clear agenda and specific proposed claim language before the interview; (2) agree on amendments or arguments during the call; (3) confirm all agreements in writing in the AIIR; (4) never make representations about the prior art scope or claim scope in an interview that you don't want to be part of the prosecution history (interviews are on the record). Studies show that applications where examiner interviews occurred reach allowance more frequently and faster than those without interviews.
What happens if I miss the deadline to respond to a patent Office Action?
If you fail to file a timely response to a USPTO Office Action within 6 months of the mailing date (the absolute maximum with extensions), your patent application is ABANDONED under 35 U.S.C. § 133. Abandonment means prosecution ceases, and the claims are no longer pending. The invention enters the public domain — anyone can practice the invention without needing a license. What you can do after abandonment: (1) Petition to Revive (Unintentional Abandonment): file a petition under 37 C.F.R. § 1.137(a) if the abandonment was 'unintentional.' The petition requires: (a) the complete response that was missing plus all necessary fees; (b) a statement that the entire delay was unintentional; (c) the petition fee ($2,000 large entity, $1,000 small entity, $500 micro entity, approximately). Revival must be sought promptly after discovering the abandonment. The USPTO may require additional showing of unintentionality for very long delays (more than 6 months after the abandonment date). (2) File a new application: if revival is impossible or denied, file a new application claiming priority to the abandoned parent under § 120 (if the parent was an original US application and prosecution occurred within the priority window) — but you cannot reclaim the abandoned application's priority date if there is intervening prior art. (3) What you CANNOT do after abandonment: you cannot simply continue paying fees or continue prosecution — once the application abandons without revival, it is gone. You cannot file a continuation of an abandoned application that was not revived. Critical warning: unintentional abandonment can happen due to a miscounted response date, a miscommunication between client and attorney, or a missed reminder. Setting multiple calendar reminders for each Office Action deadline is essential — USPTO docketing systems typically track every OA response deadline, and responsible practitioners set reminders at 1 month before the 3-month period and at 1 month before the 6-month deadline.
Related Guides